NEW YORK (GenomeWeb) – Medikonia said today it has inked a distribution agreement to make Amoy Diagnostics' range of molecular diagnostic tests available in Hong Kong and Macau.

Additional terms of the agreement were not disclosed.

Pau Huang, AmoyDx's international sales and marketing director, said in a statement that the firm's molecular diagnostic tests, which are powered by its proprietary PCR-based ADx Amplification Refractory Mutation System (ADx-ARMS) and Super-ARMS technologies, help patients receive the correct cancer drugs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.